Off label uses of hyaluronic acid fillers: A review.
Poonam TapsaleBelma TürsenÜmit TürsenPublished in: Dermatologic therapy (2022)
Food and Drug Administration approved indications of hyaluronic acid fillers include some facial wrinkles or skin folds like naso-labial folds, perioral wrinkles, volumization of lip, cheek, chin, and dorsal region of the hands, also acne scars and lipoatrophy of human immunodeficiency virus positive patients. This article reviews the off-label indications of hyaluronic acid fillers such as connective tissue disorders (lupus erythematosus, scleroderma, and dermatomyositis), lipoatrophy associated with other diseases, breast volumization, giving volume to buttocks and the feet, implant into bone, tendon, ligament or muscle, injection to glabella, nose, periorbital region, forehead, or neck.
Keyphrases
- hyaluronic acid
- human immunodeficiency virus
- drug administration
- soft tissue
- end stage renal disease
- hepatitis c virus
- interstitial lung disease
- newly diagnosed
- systemic lupus erythematosus
- antiretroviral therapy
- ejection fraction
- chronic kidney disease
- systemic sclerosis
- disease activity
- spinal cord
- hiv aids
- skeletal muscle
- bone mineral density
- spinal cord injury
- neuropathic pain
- randomized controlled trial
- risk assessment
- body composition
- ultrasound guided
- idiopathic pulmonary fibrosis
- botulinum toxin
- meta analyses